Quoin Pharmaceuticals Statistics Share Statistics Quoin Pharmaceuticals has 588.17K
shares outstanding. The number of shares has increased by -85.22%
in one year.
Shares Outstanding 588.17K Shares Change (YoY) -85.22% Shares Change (QoQ) -93.43% Owned by Institutions (%) 0.03% Shares Floating 4.13M Failed to Deliver (FTD) Shares 117 FTD / Avg. Volume 0.07%
Short Selling Information The latest short interest is 9.15K, so 1.56% of the outstanding
shares have been sold short.
Short Interest 9.15K Short % of Shares Out 1.56% Short % of Float 1.67% Short Ratio (days to cover) 2.58
Valuation Ratios The PE ratio is -0.01 and the forward
PE ratio is -0.27.
Quoin Pharmaceuticals's PEG ratio is
0.
PE Ratio -0.01 Forward PE -0.27 PS Ratio 0 Forward PS 0.3 PB Ratio 0.01 P/FCF Ratio -0.01 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Quoin Pharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.57,
with a Debt / Equity ratio of 0.
Current Ratio 3.57 Quick Ratio 3.57 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3M Employee Count 3 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -8.95B Effective Tax Rate 99.9%
Stock Price Statistics The stock price has increased by 1220.7% in the
last 52 weeks. The beta is 1.82, so Quoin Pharmaceuticals's
price volatility has been higher than the market average.
Beta 1.82 52-Week Price Change 1220.7% 50-Day Moving Average 8.47 200-Day Moving Average 4.59 Relative Strength Index (RSI) 39.06 Average Volume (20 Days) 173,127
Income Statement
Revenue n/a Gross Profit n/a Operating Income -9.57M Net Income -9.01M EBITDA -8.9M EBIT -9.01M Earnings Per Share (EPS) -1911.5
Full Income Statement Balance Sheet The company has 3.62M in cash and 0 in
debt, giving a net cash position of 3.62M.
Cash & Cash Equivalents 3.62M Total Debt n/a Net Cash n/a Retained Earnings -55.17B Total Assets 12.96M Working Capital 7.64M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.86M
and capital expenditures 0, giving a free cash flow of -7.86M.
Operating Cash Flow -7.86M Capital Expenditures n/a Free Cash Flow -7.86M FCF Per Share -58.65
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields QNRX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for QNRX is $4,
which is -43.2% lower than the current price. The consensus rating is "Buy".
Price Target $4 Price Target Difference -43.2% Analyst Consensus Buy Analyst Count 1
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 18, 2023. It was a
backward
split with a ratio of 1:12.
Last Split Date Jul 18, 2023 Split Type backward Split Ratio 1:12
Scores Altman Z-Score -8.12 Piotroski F-Score 4
